BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 38244667)

  • 1. Multitask learning for predicting pulmonary absorption of chemicals.
    Chiu YW; Tung CW; Wang CC
    Food Chem Toxicol; 2024 Mar; 185():114453. PubMed ID: 38244667
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Comparison of Drug Transport in Pulmonary Absorption Models: Isolated Perfused rat Lungs, Respiratory Epithelial Cell Lines and Primary Cell Culture.
    Bosquillon C; Madlova M; Patel N; Clear N; Forbes B
    Pharm Res; 2017 Dec; 34(12):2532-2540. PubMed ID: 28924829
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pulmonary absorption - estimation of effective pulmonary permeability and tissue retention of ten drugs using an ex vivo rat model and computational analysis.
    Eriksson J; Sjögren E; Thörn H; Rubin K; Bäckman P; Lennernäs H
    Eur J Pharm Biopharm; 2018 Mar; 124():1-12. PubMed ID: 29191716
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pulmonary drug absorption and systemic exposure in human: Predictions using physiologically based biopharmaceutics modeling.
    Eriksson J; Thörn H; Lennernäs H; Sjögren E
    Eur J Pharm Biopharm; 2020 Nov; 156():191-202. PubMed ID: 32941997
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pulmonary Dissolution of Poorly Soluble Compounds Studied in an ex Vivo Rat Lung Model.
    Eriksson J; Thörn H; Sjögren E; Holmstén L; Rubin K; Lennernäs H
    Mol Pharm; 2019 Jul; 16(7):3053-3064. PubMed ID: 31136181
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug absorption from the isolated perfused rat lung--correlations with drug physicochemical properties and epithelial permeability.
    Tronde A; Nordén B; Jeppsson AB; Brunmark P; Nilsson E; Lennernäs H; Bengtsson UH
    J Drug Target; 2003 Jan; 11(1):61-74. PubMed ID: 12852442
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of a Novel Quantitative Structure-Activity Relationship Model to Accurately Predict Pulmonary Absorption and Replace Routine Use of the Isolated Perfused Respiring Rat Lung Model.
    Edwards CD; Luscombe C; Eddershaw P; Hessel EM
    Pharm Res; 2016 Nov; 33(11):2604-16. PubMed ID: 27401409
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Computational prediction of Calu-3-based in vitro pulmonary permeability of chemicals.
    Lin HL; Chiu YW; Wang CC; Tung CW
    Regul Toxicol Pharmacol; 2022 Nov; 135():105265. PubMed ID: 36198368
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug Absorption Parameters Obtained Using the Isolated Perfused Rat Lung Model Are Predictive of Rat In Vivo Lung Absorption.
    Eriksson J; Sjögren E; Lennernäs H; Thörn H
    AAPS J; 2020 May; 22(3):71. PubMed ID: 32394314
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vivo, in vitro and ex vivo models to assess pulmonary absorption and disposition of inhaled therapeutics for systemic delivery.
    Sakagami M
    Adv Drug Deliv Rev; 2006 Oct; 58(9-10):1030-60. PubMed ID: 17010473
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fundamentals and Applications of Isolated Perfused Lung (IPL) Model in the Development of Pulmonary Drug Delivery.
    Mireskandari K; Ardakani YH; Moghadam ES; Ketabchi F; Rouini M
    Curr Drug Deliv; 2023; 20(10):1425-1440. PubMed ID: 36017864
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Advances in experimental and mechanistic computational models to understand pulmonary exposure to inhaled drugs.
    Bäckman P; Arora S; Couet W; Forbes B; de Kruijf W; Paudel A
    Eur J Pharm Sci; 2018 Feb; 113():41-52. PubMed ID: 29079338
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pulmonary absorption rate and bioavailability of drugs in vivo in rats: structure-absorption relationships and physicochemical profiling of inhaled drugs.
    Tronde A; Nordén B; Marchner H; Wendel AK; Lennernäs H; Bengtsson UH
    J Pharm Sci; 2003 Jun; 92(6):1216-33. PubMed ID: 12761811
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In silico predictions of gastrointestinal drug absorption in pharmaceutical product development: application of the mechanistic absorption model GI-Sim.
    Sjögren E; Westergren J; Grant I; Hanisch G; Lindfors L; Lennernäs H; Abrahamsson B; Tannergren C
    Eur J Pharm Sci; 2013 Jul; 49(4):679-98. PubMed ID: 23727464
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro, ex vivo and in vivo methods of lung absorption for inhaled drugs.
    Sakagami M
    Adv Drug Deliv Rev; 2020; 161-162():63-74. PubMed ID: 32763274
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of physiologically-based gut absorption model for probabilistic prediction of environmental chemical bioavailability.
    Lin HC; Chiu WA
    ALTEX; 2023; 40(3):471-484. PubMed ID: 37158362
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transfer learning for predicting human skin sensitizers.
    Tung CW; Lin YH; Wang SS
    Arch Toxicol; 2019 Apr; 93(4):931-940. PubMed ID: 30806762
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predicting the Absorption Potential of Chemical Compounds Through a Deep Learning Approach.
    Shin M; Jang D; Nam H; Lee KH; Lee D
    IEEE/ACM Trans Comput Biol Bioinform; 2018; 15(2):432-440. PubMed ID: 26930688
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dry powder inhalation exposures of the endotracheally intubated rat lung, ex vivo and in vivo: the pulmonary pharmacokinetics of fluticasone furoate.
    Selg E; Ewing P; Acevedo F; Sjöberg CO; Ryrfeldt A; Gerde P
    J Aerosol Med Pulm Drug Deliv; 2013 Aug; 26(4):181-9. PubMed ID: 23094685
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ensemble learning for predicting ex vivo human placental barrier permeability.
    Chou CY; Lin P; Kim J; Wang SS; Wang CC; Tung CW
    BMC Bioinformatics; 2022 Sep; 22(Suppl 10):629. PubMed ID: 36138350
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.